The CARES Approach to Patient-Centered Diabetes Management: One Size No Longer Fits All
PROGRAM CHAIR & PRESENTING FACULTY
Silvio Inzucchi, MD
Professor of Medicine (Endocrinology)
Yale School of Medicine
New Haven, CT
This case-based activity will cover the treatment and management of patients with diabetes.
This educational activity is intended for primary care physicians, physician assistants, nurse practitioners, pharmacists, certified diabetes educators, and other HCPs who care for patients with diabetes.
On completing the program, attendees should be able to:
- Describe how a patient-centered approach to the care of patients with type 2 diabetes mellitus (T2DM) can help improve glycemic control, reduce complications and improve patient self- management
- Assess strategies for the use of various oral and injectable medications for treatment intensification in patients with T2DM not meeting their glycemic goals
- Review updated guidelines and algorithms pertinent to the management of patients with T2DM, with or without concomitant heart failure or renal disease
- Evaluate the role of SGLT2 inhibitors and GLP-1 receptor agonists in managing cardiovascular and renal risk in patients with T2DM
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in treating and managing patients with diabetes.
CNE Credits: 2.0 ANCC Contact Hour.
COMMISION ON DIETETIC REGISTRATION
This program has received prior approval with the Commission on Dietetic Registration for dietitians and RDs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTERESTS
Silvio Inzucchi, MD, is a consultant for Boehringer Ingelheim, AstraZeneca, Sanofi/ Lexicon, Novo Nordisk, Merck, vTv Pharmaceuticals, Zafgen, Abbott/Alere, Eisai (TIMI). He has also received royalties from McGraw-Hill and Uptodate and has received salary from Elsevier.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group has nothing to disclose.
Melissa A Johnson, Sr. Program Manager of Med Learning Group has nothing to disclose.
Cindy Lampner, Scientific and Medical Services of Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator of Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Complete pre-and-post survey.
4. Submit the evaluation form online.
You will receive your certificate via downloadable PDF after the activity.
Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
RELEASE DATE: December 9, 2019
EXPIRATION DATE: December 9, 2020
Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.